TY  - JOUR
T1  - INtravitreous tissue plasminogen activator with pneumatic displacement in submacular hemorrhage
AU  - Ratra D, Basia A
Y1  - 2012/06/01
N1  - 10.1001/archophthalmol.2011.1856
JO  - Archives of Ophthalmology
SP  - 795
EP  - 796
VL  - 130
IS  - 6
N2  - 
Submacular hemorrhage–induced retinal damage appears to vary directly with the duration of hemorrhage. Hence, many investigators have advocated early evacuation of subretinal hemorrhage to minimize these damaging effects. In 1996, Heriot1 presented the benefits of the minimally invasive procedure of enzymatically liquefying the submacular blood with tissue plasminogen activator (tPA) and displacing it with gas. Many studies have since shown good results with this procedure, but the exact time of the intervention is still debatable.2- 3 Although there is no consensus, submacular bleeding for more than 28 days is generally believed to give poor results.4 We report a case of submacular bleeding for 60 days that showed dramatic clearing within a day with tPA and gas.

SN  - 0003-9950
M3  - doi: 10.1001/archophthalmol.2011.1856
UR  - http://dx.doi.org/10.1001/archophthalmol.2011.1856
ER  -